INFLUENCE OF RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY ON PLASMA LEVEL OF INSULIN-LIKE GROWTH FACTOR TYPE t (IGF1-1) IN CHRONIC HEMODIAL YSIS PA T/ENTS
Sherif Nabil M.Ali Arafa;
Abstract
There is no influence ofrllu-EPO therapy on serum
concentrations oflGF-1 in chronic hemodialysis patients. Furthermore. IGF-l bioavailability (free IGF-I) needed to be estimated through measuring the circulating IGF binding proteins in chronic hemodialysi
concentrations oflGF-1 in chronic hemodialysis patients. Furthermore. IGF-l bioavailability (free IGF-I) needed to be estimated through measuring the circulating IGF binding proteins in chronic hemodialysi
Other data
| Title | INFLUENCE OF RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY ON PLASMA LEVEL OF INSULIN-LIKE GROWTH FACTOR TYPE t (IGF1-1) IN CHRONIC HEMODIAL YSIS PA T/ENTS | Other Titles | تاثير العلاج بعقار الارثروبيوتين على مستوى عامل النمو الشبيه بالانسولين (1) فى مرضى الغسيل الدموى المزمن | Authors | Sherif Nabil M.Ali Arafa | Keywords | INFLUENCE OF RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY ON PLASMA LEVEL OF INSULIN-LIKE GROWTH FACTOR TYPE t (IGF1-1) IN CHRONIC HEMODIAL YSIS PA T/ENTS | Issue Date | 2002 | Description | There is no influence ofrllu-EPO therapy on serum concentrations oflGF-1 in chronic hemodialysis patients. Furthermore. IGF-l bioavailability (free IGF-I) needed to be estimated through measuring the circulating IGF binding proteins in chronic hemodialysi |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.